NR2F2 and breast carcinoma: Among breast cancer subtypes, its expression is highest in the luminal A subtype; although in the TNBC cell lines Bt549 and MDA-MB-231 used in this study, NR2F2 expression is comparable to that in MCF-7, a luminal A cell line (Figure S8A).